The persistently affected Lama5, Gtse1, Fabp4 and Bcl6 gene can be potential target genes for the treatment of AFB1 induced liver diseases, but their effectiveness needs to be further explored in experiments. This evidence concerns the gene LAMA5 and liver disorder.